La Jolla Pharmaceutical Company LJPC was a big mover last session, as the company saw its shares rise over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This …
La Jolla Pharmaceutical Company announces U.S. Fda acceptance of new drug application for LJPC-501 * La Jolla Pharmaceutical Co- ‍user fee goal date under prescription drug user fee act is February 28, 2018 for LJPC-501 * La Jolla …
For more information, get Portfolio Grader’s complete analysis of LEU stock. La Jolla Pharmaceutical Company. The company also gets F’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s …
After announcing that its phase 3 ATHOS-3 study would be published in a prestigious medical journal, clinical-stage biotech La Jolla Pharmaceutical (NASDAQ: LJPC) saw its shares ... David and Tom Gardner have a stock tip, it can …
Since the March sell-off, LJPC's stock had mostly languished in spite of positive analysts' recommendations. However, by the end of 2014, the stock began a rally that has led to all-time highs in 2015. This article will provide the uninitiated …
Investors in La Jolla Pharmaceutical Company LJPC need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 16th, 2017 $20 Put had some of the highest implied volatility of all equity …
Tribune Publishing Company Comm (TPUB): TPUB stock is up 1.49% today. Trovagene Inc (TROV): TROV stock is down 1.28% today. La Jolla Pharma (LJPC): LJPC stock is down 0.49% today. For more information on the best stocks to …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LJPC at https://www.zacks.com/ap/LJPC